{"created":"2024-04-29T07:19:52.909450+00:00","id":2000357,"links":{},"metadata":{"_buckets":{"deposit":"6bf57066-ec4f-4815-be64-be91a5aabe01"},"_deposit":{"created_by":11,"id":"2000357","owner":"11","owners":[11],"pid":{"revision_id":0,"type":"depid","value":"2000357"},"status":"published"},"_oai":{"id":"oai:hirosaki.repo.nii.ac.jp:02000357","sets":["557:561:1713851803406"]},"author_link":[],"control_number":"2000357","item_3_biblio_info_8":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2024-03-28","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"1-4","bibliographicPageEnd":"98","bibliographicPageStart":"87","bibliographicVolumeNumber":"74","bibliographic_titles":[{"bibliographic_title":"弘前医学","bibliographic_titleLang":"ja"},{"bibliographic_title":"Hirosaki Medical Journal","bibliographic_titleLang":"en"}]}]},"item_3_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"Background: Factor Xa inhibitors （FXaIs） have been reported to exhibit antifibrotic effects. However, their impact on the outcomes of atrial fibrillation（ AF） ablation remains unknown. This study aimed to investigate the association between freedom from atrial tachyarrhythmia recurrence and oral anticoagulant （OAC） therapy following AF ablation.\nMethods: This single-center retrospective study comprised consecutive 1,702 patients who underwent AF catheter ablation in our hospital between January 2014 and September 2021. Arrhythmia recurrence was defined as documented atrial tachyarrhythmias lasting for >30 s after the 3-month blanking period, and the recurrence rate within 12 months following ablation was compared between patients who were administered FXaIs and warfarin（ WF）.\nResults: Overall, 1,321 patients（ 916 men; mean age, 64±10 years; 947 paroxysmal and 374 persistent） who continued OAC therapy following ablation were finally followed up for 12 months. Of them, 1,222 （93%） and 99 （7%） patients were administered FXaIs and WF, respectively. During the follow-up period of 324±80 days, 115 recurrences in FXaI （33, 48, and 34 in rivaroxaban, edoxaban, and apixaban, respectively） and 13 in WF were noted. The 12-month freedom from recurrence in FXaI and WF groups was 90.0% and 85.6%, respectively, with no significant difference （P=0.21）. In multivariate analysis, FXaI treatment was not an independent factor that predicts atrial tachyarrhythmia recurrence compared with WF treatment（ hazard ratio, 0.66; 95% confidence interval, 0.37–1.20; P=0.17）.\nConclusions: Regarding atrial tachyarrhythmia recurrence following AF ablation for 12 months, no significant difference was observed between FXaIs and WF treatment as post-ablation OAC therapy.","subitem_description_language":"en","subitem_description_type":"Abstract"}]},"item_3_publisher_35":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"弘前大学大学院医学研究科","subitem_publisher_language":"ja"}]},"item_3_radio_42":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"subitem_radio_item":"Article","subitem_radio_language":"en"}]},"item_3_source_id_11":{"attribute_name":"書誌レコードID","attribute_value_mlt":[{"subitem_source_identifier":"AN00211444","subitem_source_identifier_type":"NCID"}]},"item_3_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"2434-4656","subitem_source_identifier_type":"EISSN"}]},"item_3_text_4":{"attribute_name":"著者所属","attribute_value_mlt":[{"subitem_text_language":"en","subitem_text_value":"Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine"},{"subitem_text_language":"en","subitem_text_value":"Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine"},{"subitem_text_language":"en","subitem_text_value":"Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine"},{"subitem_text_language":"en","subitem_text_value":"Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine"},{"subitem_text_language":"en","subitem_text_value":"Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine"},{"subitem_text_language":"en","subitem_text_value":"Department of Cardiac Remote Management System, Hirosaki University Graduate School of Medicine"},{"subitem_text_language":"en","subitem_text_value":"Department of Advanced Management of Cardiac Arrhythmia, Hirosaki University Graduate School of Medicine"},{"subitem_text_language":"en","subitem_text_value":"Department of Advanced Management of Cardiac Arrhythmia, Hirosaki University Graduate School of Medicine"},{"subitem_text_language":"en","subitem_text_value":"Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine"},{"subitem_text_language":"en","subitem_text_value":"Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine"},{"subitem_text_language":"en","subitem_text_value":"Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine"},{"subitem_text_language":"en","subitem_text_value":"Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine、 Department of Cardiac Remote Management System, Hirosaki University Graduate School of Medicine、 Department of Advanced Management of Cardiac Arrhythmia, Hirosaki University Graduate School of Medicine、 Department of Advanced Therapeutics for Cardiovascular Diseases, Hirosaki University Graduate School of Medicine"}]},"item_3_version_type_18":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Shota, Washima","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Shogo, Hamaura","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Yuichi, Toyama","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Kimitaka, Nishizaki","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Takahiko, Kinjo","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Yuji, Ishida","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Taihei, Itoh","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Masaomi, Kimura","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Shingo, Sasaki","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Kazumasa, Saito","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Takanobu, Soma","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Hirofumi, Tomita","creatorNameLang":"en"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_access","date":[{"dateType":"Available","dateValue":"2024-04-29"}],"filename":"Hirosaki Med J 74-1-4_87.pdf","filesize":[{"value":"654 KB"}],"format":"application/pdf","mimetype":"application/pdf","url":{"objectType":"fulltext","url":"https://hirosaki.repo.nii.ac.jp/record/2000357/files/Hirosaki Med J 74-1-4_87.pdf"},"version_id":"42096dab-7dcd-468d-a5da-001038df32a1"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"Atrial fibrillation","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Catheter ablation","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Factor Xa inhibitors","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Warfarin","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Fibrosis","subitem_subject_language":"en","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"Impact of factor Xa inhibitors on outcomes of atrial tachyarrhythmia recurrence following catheter ablation for atrial fibrillation: comparison with warfarin","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Impact of factor Xa inhibitors on outcomes of atrial tachyarrhythmia recurrence following catheter ablation for atrial fibrillation: comparison with warfarin","subitem_title_language":"en"}]},"item_type_id":"3","owner":"11","path":["1713851803406"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2024-04-29"},"publish_date":"2024-04-29","publish_status":"0","recid":"2000357","relation_version_is_last":true,"title":["Impact of factor Xa inhibitors on outcomes of atrial tachyarrhythmia recurrence following catheter ablation for atrial fibrillation: comparison with warfarin"],"weko_creator_id":"11","weko_shared_id":-1},"updated":"2024-11-20T00:30:16.184608+00:00"}